| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Vtv Therapeutics Inc. (VTVT) has 2 insiders with recent SEC Form 4 filings, including 15 buys and 0 sells. VTVT is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| Dir | 2.40M | $84.12M | - | |
| Dir | 877.2K | $30.74M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| May 27, 2016 | Savas Paul G | Director | Buy | 6,000 | $5.67 | $34,027.80 | +11.4% | |
| May 24, 2016 | Savas Paul G | Director | Buy | 1,259 | $5.26 | $6,617.80 | +0.8% | |
| Apr 8, 2016 | Perelman Ronald O | 10% Owner | Buy | 10,000 | $4.99 | $49,906.00 | +0.4% | |
| Apr 5, 2016 | Perelman Ronald O | 10% Owner | Buy | 400,000 | $5.20 | $2,079,960.00 | +9.3% | |
| Mar 28, 2016 | Savas Paul G | Director | Buy | 10,000 | $5.35 | $53,450.00 | +11.4% | |
| Mar 24, 2016 | Perelman Ronald O | 10% Owner | Buy | 10,000 | $5.64 | $56,438.00 | +0.5% | |
| Mar 7, 2016 | Savas Paul G | Director | Buy | 15,000 | $5.82 | $87,279.00 | +26.5% | |
| Feb 12, 2016 | Perelman Ronald O | 10% Owner | Buy | 10,000 | $5.83 | $58,250.00 | +0.5% | |
| Feb 5, 2016 | Perelman Ronald O | 10% Owner | Buy | 10,000 | $6.43 | $64,257.00 | +0.5% | |
| Feb 4, 2016 | Perelman Ronald O | 10% Owner | Buy | 20,000 | $6.05 | $121,030.00 | +1.0% |